2006-2019年阿根廷儿童侵袭性肺炎链球菌分离株:血清型分布与抗生素耐药性的时间演变
分析2006-2019年阿根廷5岁以下儿童2908株侵袭性肺炎链球菌分离株,比较PCV13纳入国家免疫规划前后的血清型分布与耐药性。PCV13血清型显著下降,非PCV13血清型(24群、12F)显著上升;红霉素耐药增加,主要与PCV13前14型、PCV13后24群相关。
要点
- PCV13血清型14、5、1分别显著下降91.2%、95.6%、84.6%,非PCV13血清型24群和12F分别显著上升246.7%和85.7%。
- 血清型3(7.4%)和19A(4.9%)仍为最常见血清型之一,尽管属于PCV13配方。
- 红霉素耐药增加,PCV13前主要与血清型14相关,PCV13后主要与24群相关;14、24A/B/F和19A居全抗生素耐药分离株前三位。
核心结论
- 数据强调持续监测以评估肺炎球菌疫苗和抗生素使用对肺炎球菌血清型动态影响的重要性。
研究设计与样本
- 分析2006-2019年阿根廷2908株肺炎球菌分离株,采用Neufeld-Quellung反应进行血清分型,琼脂稀释法测定对14种抗菌药物的耐药谱。
- 2012年PCV13纳入国家免疫规划,研究比较引入前后本地侵袭性肺炎球菌病流行病学。
主要发现
- 比较期间非PCV13血清型比例显著增加:24群增加246.7%,12F增加85.7%。
- PCV13血清型显著减少:血清型14下降91.2%,血清型5下降95.6%,血清型1下降84.6%。
- 血清型3(7.4%)和19A(4.9%)尽管属于PCV13配方,仍居最常见血清型之列。
- 红霉素耐药在研究期间增加,PCV13前主要与血清型14相关,PCV13后主要与24群相关,24群也是与抗菌药物耐药和多重耐药相关的主要非疫苗血清型。
- 对全部测试抗生素耐药的分离株中,血清型14、24A/B/F和19A居前三位。
临床怎么用
- 原文未据此给出推荐,仅强调持续监测以评估肺炎球菌疫苗和抗生素使用对血清型动态的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus pneumoniae is a major cause of severe invasive disease associated with high mortality and morbidity worldwide. A total of 2908 pneumococcal isolates were analyzed between 2006 and 2019. Gold standard pneumococcal serotyping (the Neufeld-Quellung reaction) was performed to identify the serotypes associated with infection in children < 5 years in Argentina and agar dilution method was carried out to determine their profiles to 14 antimicrobial agents. In 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) was included in the National Immunization Program. In this work we have analyzed the local epidemiology of invasive pneumococcal diseases before and after the introduction of this vaccine in order to understand the epidemiological relevance and impact of PCV13. During the periods compared in the present study there was a significant increase in the proportion of non-PCV13 serotypes, serogroup 24 (246.7%) and 12F (85.7%), and a significant decrease in PCV13 serotypes, including serotypes 14 (91.2%), 5 (95.6%) and 1 (84.6%) among others. Another observation was that serotypes 3 (7.4%) and 19A (4.9%) still remain among the most frequent serotypes despite being part of the PCV13 formulation. Regarding antimicrobial resistance, in the present study we observed an increase in erythromycin resistance during the period of study mainly associated to serotype 14 in the pre-PCV13 period and to serogroup 24 in the post-PCV13 period, which also was the major NVT serotype associated with antimicrobial resistance and MDR. Serotypes 14, 24A/B/F and 19A were in the first three places among isolates resistant to all the antibiotics tested. Our data highlight the importance of continuous surveillance to assess the impact of pneumococcal vaccines and the use of antibiotics in the dynamic of pneumococcal serotypes.
引用
- Zintgraff J, Gagetti P, Napoli D, et al. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine. 2021. PMID: 34920903. doi:10.1016/j.vaccine.2021.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。